---
category: news
title: "Adapsyn Bioscience enters into strategic collaboration with Evotec"
excerpt: "The Adapsyn platform uses artificial intelligence and machine learning to identify and isolate novel drug-like metabolites from microbes for downstream assay and development. Evotec has extensive biochemical,"
publishedDateTime: 2022-09-21T10:17:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/adapsyn-bioscience-enters-into-strategic-collaboration-with-evotec-1031755881"
webUrl: "https://markets.businessinsider.com/news/stocks/adapsyn-bioscience-enters-into-strategic-collaboration-with-evotec-1031755881"
type: article
quality: 34
heat: 34
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Finance
  - AI

secured: "sqsdls3IOD3WZdupmwq4wEiNOjVJrJ3SEgJrNHbgkwirUfrsL/HyzyvGCuhB8HUjlIBDs7f5IChNp89U1cUKjexJO3jW7FdCHgJMxZm80jQmk7egZCBfUKHk8kQeVIFyf/2ZUGgP7F8KDhX4YQbC7P+SJ13/QLTFNJ0cTFjuwXHnje4uMsynZlxUNVaj5kcaFyVeP1xvAbK+9jxerc7ePDyWDmvX01dUPo0cOPK3esDshVGysDZPMvVHueelejccFok23/zQdTV84Ke7FDFxWwIEPZSB7VX63iIy4rfVJzZZVT+Jk3kUL0Mrq9S0K7LK7E14S3eWhSasMQxj6+jtFL6z8RVW3jR3ZwKMREPf8M8=;YRa7LLUA9L/TBdfSRNyNfQ=="
---

